Plegridy and Vision blurred - a phase IV clinical study of FDA data

Summary:

Vision blurred is reported as a side effect among people who take Plegridy (peginterferon beta-1a), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Vitamin B12, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Vision blurred when taking Plegridy. It is created by eHealthMe based on reports of 14,748 people who have side effects when taking Plegridy from the FDA, and is updated regularly.

What is Plegridy?

Plegridy has active ingredients of peginterferon beta-1a. eHealthMe is studying from 14,764 Plegridy users. Check the latest studies of Plegridy.

What is Vision blurred?

Vision blurred is found to be associated with 2,495 drugs and 2,968 conditions by eHealthMe. Check the latest studies of Vision blurred.

On Jul, 26, 2026

14,748 people reported to have side effects when taking Plegridy.
Among them, 73 people (0.49%) have Vision blurred.

Among these 73 people:

How long have people been on Plegridy when they have Vision blurred? *

What is the gender of people who have Vision blurred when taking Plegridy? *

female: 83.1 %
male: 16.9 %

What is the age of people who have Vision blurred when taking Plegridy? *

What are other drugs people take besides Plegridy? *

What are other side effects people have besides Vision blurred? *

Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 19 people, 26.03%
Fatigue (feeling of tiredness): 19 people, 26.03%
Weakness: 18 people, 24.66%
Pain: 18 people, 24.66%
Influenza Like Illness: 17 people, 23.29%
Headache (pain in head): 17 people, 23.29%
Hypoaesthesia (reduced sense of touch or sensation): 16 people, 21.92%
Stress And Anxiety: 14 people, 19.18%
Fall: 14 people, 19.18%
Visual Impairment: 13 people, 17.81%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 62 people, 84.93%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 5.48%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 5.48%
Migraine (headache): 3 people, 4.11%
Limb Discomfort (discomfort in leg): 3 people, 4.11%
Vulvovaginal Dryness: 2 people, 2.74%
Urinary Tract Infection: 2 people, 2.74%
Stress And Anxiety: 2 people, 2.74%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 2 people, 2.74%
Pain: 2 people, 2.74%

* Approximation only. Some reports may have incomplete information.

Do you take Plegridy and have Vision blurred?

- Check whether Vision blurred is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Plegridy:

Plegridy (14,764 reports)

Vision blurred treatments and more:

Vision blurred (154,118 reports)

Browse all side effects of Plegridy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vision blurred:

Vision blurred (2,495 drugs)

Browse all the conditions that are associated with Vision blurred:

Vision blurred (2,968 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on peginterferon beta-1a (the active ingredients of Plegridy) and Plegridy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.